Polyphenolic compounds with biological activity in guabiroba fruits (Campomanesia xanthocarpaBerg.) by comprehensive two‐dimensional liquid chromatography

• DOI: 10.1002/elps.202000170
• Publication Date: 2020-08-11T07:48:04Z
• Authors: Stefany Grutzmann...; Katia Arena; Jeferson Kolling; Paloma Rocha; Paola Dugo; Luigi Mondello; Francesco Cacciola
• Keywords: 2. Zero hunger; Myrtaceae; Polyphenols; Reproducibility of Results; 01 natural sciences; Antioxidants; Mass Spectrometry; 0104 chemical sciences; Antidiabetic activity, Antioxidant activity, LC×LC, Polyphenols, Simplex-centroid design.; Limit of Detection; Fruit; Linear Models; Hypoglycemic Agents; Chromatography, Liquid

AbstractThis study aimed to evaluate the polyphenolic composition along with the biological activity of guabiroba (Campomanesia xanthocarpaBerg.) fruits using comprehensive two‐dimensional liquid chromatography (LC × LC). A simplex centroid design comprising three solvents (methanol, 2% acetic acid, and acetonitrile) was used to optimize the extraction mixture for polyphenols from ripe and unripe guabiroba fruits. A quantitative LC × LC platform was proposed to characterize the guabiroba extracts using a RP‐Amide column and a C18 column in the first and second dimensions, respectively. Antidiabetic properties, usingin vitroenzyme assay models andin vivoantioxidant activity with the eukaryote modelSaccharomyces cerevisiae, was measured. Total phenolics compounds were more efficiently extracted with 2% acetic acid solution and acetonitrile (50:50, v/v). A total of 37 different compounds were identified and quantified using the proposed LC × LC method (linearity ranging from 0.9990 to 0.9994, intra‐ and interday precision from 0.40 to 10.57% and, accuracy from 81.89 to 108.98%). Significant differences were observed between ripe and unripe guabiroba fruits, especially for the compounds geraldone and methyl galangin isomer. Guabiroba fruits showed significant antidiabetic and antioxidant properties and may be potentially adopted as part of dietary strategies in the management of early stages of type 2 diabetes and associated complications.